Numerous studies have shown that several cancer cells, including GBM cells as compared to normal cells, have higher levels of RAD51, demonstrating its involvement in resistance to IR and that RAD51 downregulation determined the radiosensitivity (36–39). Here, RAD51 is linked to cancer.